{"id":66585,"date":"2026-07-16T08:25:28","date_gmt":"2026-07-15T22:25:28","guid":{"rendered":"https:\/\/www.tomgrimshaw.com\/tomsblog\/?p=66585"},"modified":"2026-07-16T08:25:28","modified_gmt":"2026-07-15T22:25:28","slug":"ivermectin-vs-fenbendazole-vs-mebendazole","status":"publish","type":"post","link":"https:\/\/www.tomgrimshaw.com\/tomsblog\/?p=66585","title":{"rendered":"Ivermectin vs. Fenbendazole vs. Mebendazole"},"content":{"rendered":"<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-66586\" src=\"https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2026\/07\/Ivermectin_Fenbendazol_Mebendazole.jpg\" alt=\"Ivermectin vs. Fenbendazole vs. Mebendazole\" width=\"459\" height=\"680\" srcset=\"https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2026\/07\/Ivermectin_Fenbendazol_Mebendazole.jpg 459w, https:\/\/www.tomgrimshaw.com\/tomsblog\/wp-content\/uploads\/2026\/07\/Ivermectin_Fenbendazol_Mebendazole-203x300.jpg 203w\" sizes=\"auto, (max-width: 459px) 100vw, 459px\" \/><\/p>\n<p>Many patients have inquired about the need to use Ivermectin, Fenbendazole, and Mebendazole simultaneously. This will clarify the situation for you. Each of these substances operates through distinct mechanisms and targets cancer in unique ways.<\/p>\n<p>Ivermectin vs. Fenbendazole vs. Mebendazole: 12 Powerful Anti-Cancer Mechanisms Each Uses to Attack Tumors<\/p>\n<p>These repurposed medications were originally designed to fight parasites \u2014 but research and real-world use have shown they do much more. Each one attacks cancer on multiple biological fronts, helping shut down tumor growth, starve cancer cells, boost the immune system, and more.<\/p>\n<p>Here\u2019s a breakdown of how each works:<\/p>\n<p>IVERMECTIN \u2013 12 Known Anti-Cancer Actions<br \/>\n1. Inhibits WNT\/\u00df-catenin pathway \u2013 stops cancer cell proliferation<br \/>\n2. Induces apoptosis \u2013 triggers programmed cancer cell death<br \/>\n3. Blocks importin a\/\u00df transport proteins \u2013 prevents cancer cell replication<br \/>\n4. Inhibits PAK1 enzyme \u2013 reduces inflammation and tumor progression<br \/>\n5. Anti-angiogenic \u2013 stops formation of new blood vessels in tumors<br \/>\n6. Immune system modulator \u2013 enhances recognition of cancer cells<br \/>\n7. Autophagy disruptor \u2013 interferes with cancer cell survival strategies<br \/>\n8. Targets glioblastoma stem cells \u2013 effective in brain cancers<br \/>\n9. Inhibits mitochondrial respiration \u2013 cuts off energy supply to tumors<br \/>\n10. Disrupts mTOR signaling \u2013 slows cell growth<br \/>\n11. Overcomes chemotherapy resistance \u2013 makes chemo more effective<br \/>\n12. Antiviral properties \u2013 potentially helpful for virus-related cancers (like HPV)<\/p>\n<p>FENBENDAZOLE \u2013 12 Known Anti-Cancer Actions<br \/>\n1. Microtubule disruption \u2013 prevents cancer cells from dividing<br \/>\n2. Inhibits glucose uptake \u2013 starves cancer cells of energy<br \/>\n3. Activates p53 tumor suppressor gene \u2013 helps kill damaged cells<br \/>\n4. Triggers apoptosis (cell death) \u2013 particularly in lung, colon, and prostate cancer<br \/>\n5. Inhibits metastasis \u2013 prevents cancer from spreading<br \/>\n6. Enhances oxidative stress in cancer cells \u2013 makes them more vulnerable<br \/>\n7. Immune modulator \u2013 may help immune system target tumors<br \/>\n8. Blocks angiogenesis \u2013 stops tumors from building blood supply<br \/>\n9. Depletes glutathione in tumors \u2013 weakens their defense<br \/>\n10. Suppresses AKT signaling pathway \u2013 involved in cell survival<br \/>\n11. Restores normal cell cycle regulation \u2013 prevents uncontrolled growth<br \/>\n12. Synergistic with other natural agents (e.g., CBD, curcumin, vitamin D)<\/p>\n<p>MEBENDAZOLE \u2013 12 Known Anti-Cancer Action<br \/>\n1. Microtubule destabilization \u2013 similar to fenbendazole<br \/>\n2. Inhibits angiogenesis blocks new blood vessel growth<br \/>\n3. Triggers apoptosis \u2013 causes cancer cell death<br \/>\n4. Inhibits VEGF signaling \u2013 blocks tumor blood supply signals<br \/>\n5. Crosses blood-brain barrier \u2013 useful for brain cancers<br \/>\n6. Activates caspase-3\/7 enzymes \u2013 involved in programmed cell death<br \/>\n7. Reduces MYC oncogene expression \u2013 slows tumor growth<br \/>\n8. Inhibits Bcl-2 protein \u2013 lowers cancer cell survival<br \/>\n9. Anti-metastatic \u2013 reduces spread of cancer<br \/>\n10. Disrupts mitochondrial function \u2013 energy production in tumor cells fails<br \/>\n11. Improves chemo sensitivity \u2013 helps standard treatments work better<br \/>\n12. Low toxicity + long safety record \u2013 used in humans for decades<\/p>\n<p>Each of these medications targets cancer through different biological pathways. If you see this post and you have not been following me please do so to get daily updates on important information like this. The world needs to know about this.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Many patients have inquired about the need to use Ivermectin, Fenbendazole, and Mebendazole simultaneously. This will clarify the situation for you. Each of these substances operates through distinct mechanisms and targets cancer in unique ways. Ivermectin vs. Fenbendazole vs. Mebendazole: 12 Powerful Anti-Cancer Mechanisms Each Uses to Attack Tumors These repurposed medications were originally designed &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.tomgrimshaw.com\/tomsblog\/?p=66585\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Ivermectin vs. Fenbendazole vs. Mebendazole&#8221;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5,6],"tags":[],"class_list":["post-66585","post","type-post","status-publish","format-standard","hentry","category-general-interest","category-health-tips"],"_links":{"self":[{"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/posts\/66585","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=66585"}],"version-history":[{"count":1,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/posts\/66585\/revisions"}],"predecessor-version":[{"id":66587,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=\/wp\/v2\/posts\/66585\/revisions\/66587"}],"wp:attachment":[{"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=66585"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=66585"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.tomgrimshaw.com\/tomsblog\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=66585"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}